GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets IP

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets IP
Each film coated Tablet contains:
Rifampicin IP………………………………..…150mg
Isoniazid IP……………………………………..75mg
Ethambutol Hydrochloride IP………….275mg
Excipients……………………………............q.s
Colour: Sunset Yellow FCF

THERAPEUTIC INDICATIONS:

This combination is used in the treatment of tuberculosis. rifampicin works by inactivating a bacterial enzyme (rna-polymerase) which is required by tb bacteria to make essential proteins and to reproduce, while isoniazid prevents these bacteria from forming their own protective covering. together, they kill the bacteria and eradicate the infection. ethambutol, on the other hand works by slowing the growth of these bacteria.

CAUTION & WARNING:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablets to be swallowed as a whole, and not to be chewed or crushed.

SCHEDULE H1 PRESCRIPTION DRUG- WARNING:
- It is dangerous to take this preparation except in accordance with the medical advice.
-Not to be sold by retail without the prescription of registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by physician.

Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets IP 150mg+75mg+275mg Technical specification:

Product Name: Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets IP
Brand Name: Generic name
Strength: 150mg+75mg+275mg
Dosage Form: Tablet (film-coated)
Route of Administration: Via Oral Route
Packing: 10 strips of 10 Tablets each
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Anti-tuberculosis
Indication: This combination is used in the treatment of tuberculosis.
Storage: Store at temperature not exceeding 30℃. Store in cool, dry & dark place Protect from Light & moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets IP 150mg+75mg+275mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets IP
    Each film coated Tablet contains:
    Rifampicin IP………………………………..…150mg
    Isoniazid IP……………………………………..75mg
    Ethambutol Hydrochloride IP………….275mg
    Excipients………………………………………q.s
    Colour: Sunset Yellow FCF

THERAPEUTIC INDICATIONS:

  • This combination is used in the treatment of tuberculosis. rifampicin works by inactivating a bacterial enzyme (rna-polymerase) which is required by tb bacteria to make essential proteins and to reproduce, while isoniazid prevents these bacteria from forming their own protective covering. together, they kill the bacteria and eradicate the infection. ethambutol, on the other hand works by slowing the growth of these bacteria.

CAUTION & SCHEDULE:

  • CAUTION:  Read enclosed leaflet before use.
    Keep medicine out of reach of children.
    Tablets to be swallowed as a whole, and not to be chewed or crushed.

SCHEDULE H1 PRESCRIPTION DRUG- WARNING:
– It is dangerous to take this preparation except in accordance with the medical advice.

-Not to be sold by retail without the prescription of registered Medical Practitioner.

STORAGE & DOSAGE:

  • Storage: Store at temperature not exceeding 30℃. Store in cool, dry & dark place.  Protect from Light & moisture.
  • Dosage:As directed by physician.